Galantamine
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period (NCT00299676) | Janssen-Cilag Pty Ltd | 2005-05-01 |
Track Galantamine automatically
Every clearance here is in the API, with alerts when new ones post.